These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 954241)

  • 1. Platelet function in patients on long term peritoneal dialysis.
    Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G
    Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function in dialyzed and non-dialyzed patients with chronic renal failure.
    Lindsay RM; Moorthy AV; Koens F; Linton AL
    Clin Nephrol; 1975 Aug; 4(2):52-7. PubMed ID: 1157351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-thromboglobulin levels in chronic renal failure patients.
    Akizawa T; Nishiyama H; Koshikawa S
    Artif Organs; 1981 Feb; 5(1):54-8. PubMed ID: 6166286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of two different dialysis membranes on leukocyte adhesion and aggregation.
    Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G
    Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peritoneal dialysis in the aged].
    Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
    Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation].
    Myśliwiec M; Popławski A; Soszka J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):76-8. PubMed ID: 1845699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet factor 3 in normal subjects and patients with renal failure.
    Rabiner SF; Hrodek O
    J Clin Invest; 1968 Apr; 47(4):901-12. PubMed ID: 5641625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term survival between hemodialysis and peritoneal dialysis.
    Maiorca R; Cancarini GC; Brunori G; Zubani R; Camerini C; Manili L; Movilli E
    Adv Perit Dial; 1996; 12():79-88. PubMed ID: 8865878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of retention, adhesion and propagation of blood platelets in patients with chronic kidney failure and the effect of hemodialysis on blood platelet function parameters].
    Reuter H; Gessner K; Uibel-Nuhs H; Linker H; Sieberth G
    Verh Dtsch Ges Inn Med; 1974; 80():757-60. PubMed ID: 4454656
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet dysfunction and end-stage renal disease.
    Kaw D; Malhotra D
    Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].
    Janicka L; Majdan M; Dmoszyńska A; Ksiazek A; Berger B; Baranowska E
    Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
    Praga C; Brancaccio D; Pogliani E; Della Grazia M
    Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
    [No Abstract]   [Full Text] [Related]  

  • 18. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
    Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
    Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood platelet function in chronic renal insufficiency and the influence of hemodialysis].
    Cepelák V; Prokop J; Petrlík M
    Vnitr Lek; 1974 Jul; 20(6):528-38. PubMed ID: 4844787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.